Circ-LDLRAD3/miR-655-3p/MAPK1 axis enhances cell migration and invasion in papillary thyroid carcinoma. | Circ-LDLRAD3/miR-655-3p/MAPK1 axis enhances cell migration and invasion in papillary thyroid carcinoma. Zhang B, Peng Y, Zhou L. | 03/14/2024 |
circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition. | circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition. Liang Q, Chu F, Zhang L, Jiang Y, Li L, Wu H., Free PMC Article | 05/17/2023 |
Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3. | Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3. Ma B, Huang C, Ma J, Xiang Y, Zhang X. | 02/12/2022 |
Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor. | Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor. Basore K, Ma H, Kafai NM, Mackin S, Kim AS, Nelson CA, Diamond MS, Fremont DH., Free PMC Article | 02/12/2022 |
Circ-LDLRAD3 Enhances Cell Growth, Migration, and Invasion and Inhibits Apoptosis by Regulating MiR-224-5p/NRP2 Axis in Gastric Cancer. | Circ-LDLRAD3 Enhances Cell Growth, Migration, and Invasion and Inhibits Apoptosis by Regulating MiR-224-5p/NRP2 Axis in Gastric Cancer. Wang Y, Yin H, Chen X. | 12/4/2021 |
Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137. | Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137. Xue M, Hong W, Jiang J, Zhao F, Gao X., Free PMC Article | 09/18/2021 |
LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. | LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. Ma H, Kim AS, Kafai NM, Earnest JT, Shah AP, Case JB, Basore K, Gilliland TC, Sun C, Nelson CA, Thackray LB, Klimstra WB, Fremont DH, Diamond MS., Free PMC Article | 03/6/2021 |
Increased expression of circ-LDLRAD3 was indicative of a poor prognosis in patients with pancreatic cancer. Knockdown of circ-LDLRAD3 repressed the growth of pancreatic cancer in vitro and in vivo. miR-137-3p was identified as a direct target of circ-LDLRAD3. Upregulation of circ-LDLRAD3 could mitigate the inhibitory effect of miR-137-3p on the proliferation, migration and invasion of pancreatic cancer tissue and cells. | Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Yao J, Zhang C, Chen Y, Gao S. | 02/15/2020 |
Data suggest that circular RNA circ-LDLRAD3 may be a biomarker in the diagnosis of pancreatic cancer. | Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. Yang F, Liu DY, Guo JT, Ge N, Zhu P, Liu X, Wang S, Wang GX, Sun SY., Free PMC Article | 08/11/2018 |
LRAD3 is a component of pathways that function effectively to modulate Itch and Nedd4 auto-ubiquitination and levels. | Regulation of Itch and Nedd4 E3 Ligase Activity and Degradation by LRAD3. Noyes NC, Hampton B, Migliorini M, Strickland DK. | 07/30/2016 |
LRAD3 that modulates amyloid precursor protein trafficking. | LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking. Ranganathan S, Noyes NC, Migliorini M, Winkles JA, Battey FD, Hyman BT, Smith E, Yepes M, Mikhailenko I, Strickland DK., Free PMC Article | 02/8/2012 |
Observational study of gene-disease association. (HuGE Navigator) | Analysis of 9p24 and 11p12-13 regions in autism spectrum disorders: rs1340513 in the JMJD2C gene is associated with ASDs in Finnish sample. Kantojärvi K, Onkamo P, Vanhala R, Alen R, Hedman M, Sajantila A, Nieminen-von Wendt T, Järvelä I. | 06/30/2010 |
Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article | 06/30/2010 |